Article
Management Dilemma in Choosing Evolving Treatments in Neutropenic Septic Shock
2025-03-14
Abstract excerpt
<title>Abstract</title> <p>How does a physician decide to use a recently FDA-approved life-saving device in a desperately ill child in which little prior clinical experience is available? This report presents a pediatric patient with neutropenic septic shock and multiorgan failure (MOF) with a 95% chance of death and the availability of a therapeutic device with a completely new approach to treat sepsis. This dev...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b3e576c6-99f8-5fb5-be15-82251f5ae476
- DOI
- 10.21203/rs.3.rs-6221280/v1
